Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
MitoChem Therapeutics Logo
MitoChem Therapeutics Growth Score
44
CB Rank
64046
Heat Score
58
MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.
Founded
obfuscation
PrivateVenture - Series Unknown Charleston, South Carolina, United States1-10 www.mitocheminc.com
Biotechnology
Health Care
Life Science
Neuroscience
Pharmaceutical
Therapeutics
Overview

MitoChem Therapeutics
Total Funding
obfuscation
Growth Score
44
Heat Score
58

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score44
-1 pts
in past quarter
Heat Score 58
2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About MitoChem Therapeutics

CB Rank
64046
MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.
Founded
obfuscation
PrivateVenture - Series Unknown Charleston, South Carolina, United States1-10 www.mitocheminc.com
Biotechnology
Health Care
Life Science
Neuroscience
Pharmaceutical
Therapeutics

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Corporate Round
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name MitoChem Therapeutics, Inc.
Operating Status Active
Company Type For Profit
Founders  Bärbel Rohrer, Craig Beeson (1958-2019)
About the Company
MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative disease. It was founded by Craig Beeson and Bärbel Rohrer in Charleston, South Carolina.
Phone Number 520-204-5552
Contact Email contact@mitocheminc.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Insight

See this Growth Insight
MitoChem Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

MC16
A small molecule that up-regulates pro-survival and anti-oxidant pathways, aimed at treating retinitis pigmentosa and other retinal degenerative diseases.
Mitochondrial Protective Compounds Library
A collection of compounds designed to protect mitochondrial function and address neurodegenerative and aging diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - MitoChem Therapeutics Logo
Venture Round - MitoChem Therapeutics
1
obfuscation
SC Launch, Inc.Venture - Series Unknown
obfuscation
Venture Round - MitoChem Therapeutics Logo
Venture Round - MitoChem Therapeutics
1
obfuscation
SC Launch, Inc.Venture - Series Unknown
obfuscation
Venture Round - MitoChem Therapeutics Logo
Venture Round - MitoChem Therapeutics
1
obfuscation
SC Launch, Inc.Venture - Series Unknown
obfuscation
Venture Round - MitoChem Therapeutics Logo
Venture Round - MitoChem Therapeutics
1
obfuscation
SC Launch, Inc.Venture - Series Unknown
obfuscation
Venture Round - MitoChem Therapeutics Logo
Venture Round - MitoChem Therapeutics
1
obfuscation
SC Launch, Inc.Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - MitoChem Therapeutics Logo
Venture Round - MitoChem Therapeutics
1
obfuscation
SC Launch, Inc.Venture - Series Unknown
obfuscation
Venture Round - MitoChem Therapeutics Logo
Venture Round - MitoChem Therapeutics
1
obfuscation
SC Launch, Inc.Venture - Series Unknown
obfuscation
Venture Round - MitoChem Therapeutics Logo
Venture Round - MitoChem Therapeutics
1
obfuscation
SC Launch, Inc.Venture - Series Unknown
obfuscation
Venture Round - MitoChem Therapeutics Logo
Venture Round - MitoChem Therapeutics
1
obfuscation
SC Launch, Inc.Venture - Series Unknown
obfuscation
Venture Round - MitoChem Therapeutics Logo
Venture Round - MitoChem Therapeutics
1
obfuscation
SC Launch, Inc.Venture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News

News and Press

News•Sep 21, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 6, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 23, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

178
47.11%
 in past month

IT Spend

$98.4KThis year, MitoChem Therapeutics is projected to spend $98.4K on IT, according to Aberdeen.

Active Website Tech Count

3MitoChem Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is MitoChem Therapeutics's headquarters? MitoChem Therapeutics is located in Charleston, South Carolina, United States.Who invested in MitoChem Therapeutics? MitoChem Therapeutics has 4 investors including SC Launch, Inc. and  Ichor Life Sciences.When was the last funding round for MitoChem Therapeutics? MitoChem Therapeutics closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are MitoChem Therapeutics's competitors? Alternatives and possible competitors to MitoChem Therapeutics may include Amylyx Pharmaceuticals, Alzheon, and  Sarepta Therapeutics.How much funding has MitoChem Therapeutics raised to date? MitoChem Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(b82cf0e 1)
|